Cargando…
COVID-19 Disease and Dermatomyositis: A Mini-Review
The pandemic of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has caused a large number of deaths, and there is still no effective treatment. COVID-19 can induce a systemic inflammatory response, and its clinical manifestations are diverse. Recently, it has been reported that COVID-19 pat...
Autores principales: | Qian, Jie, Xu, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792859/ https://www.ncbi.nlm.nih.gov/pubmed/35095837 http://dx.doi.org/10.3389/fimmu.2021.747116 |
Ejemplares similares
-
Case Report: Concurrence of Dermatomyositis and Autoimmune Blistering Diseases: Two Case Reports and a Literature Review
por: Wu, Haixi, et al.
Publicado: (2022) -
New-onset dermatomyositis following COVID-19: A case report
por: Shimizu, Hiroshi, et al.
Publicado: (2022) -
Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review
por: Zhu, Ying, et al.
Publicado: (2023) -
Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study
por: Zhou, Shuang, et al.
Publicado: (2022) -
Malignancies in systemic rheumatic diseases: A mini review
por: Geng, Zhe, et al.
Publicado: (2023)